Bank of America’s ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) ECTE Stock Holding History

Bank of America’s Portfolio ECTE Stock Details ECTE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-74	Closed	–	–	7673
2016 Q2	$0	Buy	+74	New	+$119	﹤0.01%	7645
2015 Q3	–	Sell	-82	Closed	–	–	7644
2015 Q2	$0	Buy	+82	New	+$137	﹤0.01%	7584
2014 Q4	–	Sell	-2,089	Closed	-$2K	–	8231
2014 Q3	$2K	Buy	2,089 +1,959	+1,507%	+$3.53K	﹤0.01%	7835
2014 Q2	$0	Sell	130 -950	-88%	-$2.36K	﹤0.01%	8384
2014 Q1	$3K	Buy	1,080 +944	+694%	+$3.11K	﹤0.01%	7503
2013 Q4	$0	Sell	136 -94	-41%	-$262	﹤0.01%	8377
2013 Q3	$0	Buy	230 +177	+334%	+$479	﹤0.01%	8188
2013 Q2	$0	Buy	+53	New	+$278	﹤0.01%	7849

Other funds holding ECTE

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

AIM

Acrospire Investment Management Chicago, Illinois $33K AUM 24.6% 1-Year Est. Return

Bank of America's ECTE Position: Q3 2016 in Review

Bank of America sold out of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) in Q3 2016, closing a stake of 74 shares.

Bank of America first reported a position in ECTE in Q2 2013 and held it in 8 quarters. The position peaked at $3K in Q1 2014. 2 funds tracked by Wall St. Rank hold ECTE as of Q3 2016.

Bank of America reported no remaining ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position as of Q3 2016 after selling out during the quarter.
Bank of America sold 74 ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) shares in Q3 2016.
Bank of America first reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in Q2 2013 and held it in 8 quarters.
Bank of America's ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) position peaked at $3K in Q1 2014.
2 funds tracked by Wall St. Rank held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) as of Q3 2016.

Based on Bank of America's 13F filing for Q3 2016, filed 14 Nov 2016.